StoneX Group’s Johnson & Johnson JNJ Stock Holding History

StoneX Group’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.91M	Sell	27,201 -941	-3%	-$219K	0.28%	58
2026 Q1	$6.88M	Sell	28,142 -18,409	-40%	-$4.29M	0.37%	49
2025 Q4	$9.63M	Buy	46,551 +163	+0.4%	+$32.2K	0.42%	38
2025 Q3	$8.6M	Sell	46,388 -1,397	-3%	-$239K	0.37%	51
2025 Q2	$7.3M	Buy	47,785 +1,954	+4%	+$300K	0.35%	50
2025 Q1	$7.6M	Buy	45,831 +2,770	+6%	+$433K	0.42%	43
2024 Q4	$6.23M	Buy	43,061 +11,111	+35%	+$1.72M	0.34%	58
2024 Q3	$5.18M	Buy	31,950 +1,052	+3%	+$168K	0.38%	49
2024 Q2	$4.52M	Buy	30,898 +3,205	+12%	+$477K	0.36%	57
2024 Q1	$4.38M	Buy	27,693 +3,950	+17%	+$629K	0.39%	50
2023 Q4	$3.72M	Buy	23,743 +1,418	+6%	+$217K	0.37%	53
2023 Q3	$3.48M	Sell	22,325 -181	-0.8%	-$29.9K	0.38%	50
2023 Q2	$3.73M	Buy	22,506 +748	+3%	+$121K	0.39%	50
2023 Q1	$3.37M	Buy	21,758 +1,718	+9%	+$277K	0.37%	49
2022 Q4	$3.54M	Buy	20,040 +1,096	+6%	+$189K	0.42%	39
2022 Q3	$3.09M	Buy	18,944 +1,174	+7%	+$199K	0.42%	40
2022 Q2	$3.15M	Sell	17,770 -297	-2%	-$52.9K	0.39%	44
2022 Q1	$3.2M	Buy	18,067 +996	+6%	+$169K	0.26%	78
2021 Q4	$2.92M	Buy	17,071 +2,169	+15%	+$355K	0.34%	65
2021 Q3	$2.41M	Sell	14,902 -444	-3%	-$75.7K	0.35%	62
2021 Q2	$2.53M	Buy	15,346 +1,263	+9%	+$209K	0.37%	51
2021 Q1	$2.31M	Buy	14,083 +288	+2%	+$46.6K	0.42%	40
2020 Q4	$2.17M	Buy	13,795 +1,136	+9%	+$168K	0.48%	33
2020 Q3	$1.89M	Buy	12,659 +1,443	+13%	+$214K	0.61%	32
2020 Q2	$1.58M	Buy	11,216 +1,169	+12%	+$170K	0.6%	31
2020 Q1	$1.32M	Buy	10,047 +813	+9%	+$115K	0.7%	30
2019 Q4	$1.35M	Buy	9,234 +1,589	+21%	+$216K	0.55%	50
2019 Q3	$989K	Buy	7,645 +1,359	+22%	+$179K	0.62%	47
2019 Q2	$875K	Buy	6,286 +539	+9%	+$74.6K	0.56%	52
2019 Q1	$803K	Buy	5,747 +717	+14%	+$96K	0.61%	47
2018 Q4	$649K	Sell	5,030 -281	-5%	-$39.2K	0.63%	50
2018 Q3	$734K	Buy	5,311 +625	+13%	+$83.1K	0.54%	57
2018 Q2	$569K	Buy	4,686 +1,506	+47%	+$188K	0.49%	67
2018 Q1	$408K	Buy	3,180 +275	+9%	+$37.2K	0.39%	92
2017 Q4	$406K	Buy	2,905 +226	+8%	+$31.5K	0.42%	80
2017 Q3	$348K	Sell	2,679 -30,230	-92%	-$4.01M	0.43%	95
2017 Q2	$4.35M	Buy	+32,909	New	+$4.2M	1.36%	3
2017 Q1	–	Sell	-11,485	Closed	-$1.32M	–	68
2016 Q4	$1.32M	Sell	11,485 -1,104	-9%	-$128K	2.31%	9
2016 Q3	$1.49M	Buy	+12,589	New	+$1.53M	3.32%	4

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

StoneX Group's JNJ Position: Q2 2026 in Review

StoneX Group reduced its Johnson & Johnson (JNJ) stake by 3.3% in Q2 2026, selling an estimated $219K and leaving 27,201 shares worth $6.91M. The position accounts for 0.28% of the portfolio, ranked #58.

StoneX Group first reported a position in JNJ in Q3 2016 and has held it in 39 quarters since. The position peaked at $9.63M in Q4 2025. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

StoneX Group held 27,201 shares of Johnson & Johnson worth $6.91M as of Q2 2026.
StoneX Group sold 941 Johnson & Johnson shares in Q2 2026, an estimated $219K.
Johnson & Johnson made up 0.28% of StoneX Group's portfolio in Q2 2026, its #58 holding.
StoneX Group first reported a position in Johnson & Johnson in Q3 2016 and has held it in 39 quarters since.
StoneX Group's Johnson & Johnson position peaked at $9.63M in Q4 2025.
4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.